Marcq en Baroeul, France

Nadira Delhem

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cellvax, Centre National De La Recherche Scientifique, Institut Gustave Roussy. Active years: 2021-2026.


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Nadira Delhem

Introduction

Nadira Delhem, an accomplished inventor based in Marcq en Baroeul, France, has made significant contributions to the field of biotechnology. With one patent to her name, her work focuses on a groundbreaking antibody aimed at enhancing treatment methodologies for diseases influenced by regulatory T lymphocytes, particularly cancer.

Latest Patents

Nadira Delhem's patent is titled "Antibody which is directed against galectin-9 and is an inhibitor of the suppressor activity of regulatory T lymphocytes." This innovative invention pertains to an antibody that targets galectin-9, effectively inhibiting the suppressor activity of regulatory T lymphocytes. The patent not only outlines the properties of this antibody but also emphasizes its potential application in treating diseases related to the suppressor activity of these cells, particularly in the realm of cancer treatment.

Career Highlights

Throughout her career, Nadira has worked at prestigious institutions, contributing her expertise to various research projects. She has held positions at Université de Lille and Centre National de La Recherche Scientifique, where she has collaborated with fellow researchers and contributed to the advancement of scientific knowledge in her field.

Collaborations

Nadira has had the privilege of working alongside esteemed colleagues, including Pierre Busson and Olivier Morales. These collaborations have allowed her to enrich her research and expand the potential applications of her inventions within the scientific community.

Conclusion

Nadira Delhem stands out as an innovative inventor in the biotechnology sector. Her patent on an antibody targeting galectin-9 presents new opportunities for treating complex diseases like cancer. With a solid foundation built on esteemed collaborations and professional affiliations, Nadira continues to contribute valuable advancements to medical science, showcasing the vital role of inventors in improving healthcare outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…